Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03669822 · ClinicalTrials.gov registry record
Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)
A clinical trial of Ulcerative Colitis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT03669822: Completed study of Ulcerative Colitis, sponsored by Johns Hopkins University.
NCT03669822 is a study of Ulcerative Colitis that has completed, run by Johns Hopkins University. The registered enrollment target is 97 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03669822, a study of Ulcerative Colitis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
Ulcerative colitis (UC) is a chronic, progressive immunologically mediated disease affecting nearly 1 million Americans. Up to one third of patients with UC will require hospitalization for severe disease (termed 'acute severe colitis (ASUC)'), often within the first year after diagnosis. Investigators will develop a large multi-center cohort of patients with ASUC with homogeneously collected detailed longitudinal clinical and laboratory data.
Conditions Studied
Interventions
- OTHER Standard of care
Study Locations (1)
Maryland
- Joanna Melia - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-11-10 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03669822
The ClinicalTrials.gov registry entry for NCT03669822 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (95% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Standard of care is the first listed.
NCT03669822 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03669822 about?
NCT03669822 is a clinical study titled "Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)". Ulcerative colitis (UC) is a chronic, progressive immunologically mediated disease affecting nearly 1 million Americans. Up to one third of patients with UC will require hospitalization for severe disease (termed 'acute severe colitis (ASUC)'), often within the first year after diagnosis. Investigat...
What is the current status of trial NCT03669822?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2018-11-10. Estimated completion is 2024-12-31.
What conditions does trial NCT03669822 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
What interventions are being tested in trial NCT03669822?
The interventions under investigation include: Standard of care (OTHER).
Who is sponsoring clinical trial NCT03669822?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03669822 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.